These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 9056582)
1. Commentary on individual bioequivalence by M.-L. Chen. Hauck WW; Anderson S J Biopharm Stat; 1997 Mar; 7(1):13-6. PubMed ID: 9056582 [No Abstract] [Full Text] [Related]
2. Discussion of individual bioequivalence by M.-L. Chen. Gould AL J Biopharm Stat; 1997 Mar; 7(1):23-9. PubMed ID: 9056584 [TBL] [Abstract][Full Text] [Related]
3. On TIER method for assessment of individual bioequivalence. Ju HL J Biopharm Stat; 1997 Mar; 7(1):63-85. PubMed ID: 9056589 [TBL] [Abstract][Full Text] [Related]
4. Extension to the use of tolerance intervals for the assessment of individual bioequivalence. Esinhart JD; Chinchilli VM J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583 [TBL] [Abstract][Full Text] [Related]
5. Some issues for the consideration of individual bioequivalence. Endrenyi L J Biopharm Stat; 1997 Mar; 7(1):35-9. PubMed ID: 9056586 [No Abstract] [Full Text] [Related]
12. A log-normal model for individual bioequivalence. Phillips KF J Biopharm Stat; 1993 Sep; 3(2):185-201. PubMed ID: 8220403 [TBL] [Abstract][Full Text] [Related]
13. Types of bioequivalence and related statistical considerations. Hauck WW; Anderson S Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546 [TBL] [Abstract][Full Text] [Related]
14. The assessment of individual and population bioequivalence. Chinchilli VM J Biopharm Stat; 1996 Mar; 6(1):1-14. PubMed ID: 8838775 [TBL] [Abstract][Full Text] [Related]
15. Assessing individual bioequivalence using the structural equation model. Carrasco JL; Jover L Stat Med; 2003 Mar; 22(6):901-12. PubMed ID: 12627408 [TBL] [Abstract][Full Text] [Related]
16. Considerable cost savings through the analysis of pooled plasma samples in bioequivalence studies that fail to show bioequivalence. Hundt HK; Schall R; Luus HG; Müller FO Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):331-6. PubMed ID: 8370632 [TBL] [Abstract][Full Text] [Related]
17. A method for the evaluation of individual bioequivalence. Endrenyi L Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334 [TBL] [Abstract][Full Text] [Related]
18. Mean difference vs. variability reduction: tradeoffs in aggregate measures for individual bioequivalence. FDA Individual Bioequivalence Working Group. Hauck WW; Chen ML; Hyslop T; Patnaik R; Schuirmann D; Williams R Int J Clin Pharmacol Ther; 1996 Dec; 34(12):535-41. PubMed ID: 8996848 [TBL] [Abstract][Full Text] [Related]
19. Commentary on the publication of the study by Plavsić et al., "Bioequivalence of two oral cyclosporine preparations" in Arzneim.-Forsch./Drug Res. 45 (II), No.8, p. 914-917 (1995). Holt DW; Johnston A Arzneimittelforschung; 1995 Nov; 45(11):1242-4. PubMed ID: 8929249 [No Abstract] [Full Text] [Related]